AXIOS April 2, 2025
Veterinarians, population researchers, records officers and neuroscientists were all swept up in a chaotic series of layoffs Tuesday that effectively ended the government’s health establishment as we know it.
The big picture: The sheer breadth of the cuts and reshuffling may not be apparent for weeks. But in the immediate aftermath, health care industry players and former federal workers say the workforce reductions will almost certainly affect drug approvals, low-income assistance, disease tracking and biomedical research once held up as the gold standard.
- “The rapid and substantial changes at [the Food and Drug Administration] this week raise questions about the agency’s ability to fulfill its mission to bring new innovative medicines to patients,” said Alex Schriver, senior vice president...